|
OMIM |
Link |
Information gain |
01 |
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.0208932
|
|
|
leber optic atrophy
|
[NCBI]
|
0.0148771
|
|
|
KSS
|
[NCBI]
|
0.00833109
|
|
|
RA
|
[NCBI]
|
0.00223368
|
|
|
MTTL1
|
[NCBI]
|
0.00197466
|
|
|
MELAS
|
[NCBI]
|
0.00196809
|
|
|
MEHMO
|
[NCBI]
|
0.00192188
|
|
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.00192188
|
|
|
STUT2
|
[NCBI]
|
0.00192188
|
|
|
MTND4
|
[NCBI]
|
0.00182966
|
|
|
LS
|
[NCBI]
|
0.00182657
|
|
|
SLE
|
[NCBI]
|
0.00167561
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
0.00151757
|
|
|
MTATP6
|
[NCBI]
|
0.00147119
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
0.00144204
|
|
|
MAFD1
|
[NCBI]
|
0.00143886
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.00140088
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.00140088
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
0.00138058
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
0.001327
|
|
|
AUTS5
|
[NCBI]
|
0.00120565
|
|
|
MTND1
|
[NCBI]
|
0.00113546
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
0.00108314
|
|
|
DFN2
|
[NCBI]
|
0.00107966
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
0.00106656
|
|
|
MTCO2
|
[NCBI]
|
0.000992964
|
|
|
HYPX
|
[NCBI]
|
0.000986568
|
|
|
MERRF
|
[NCBI]
|
0.000923697
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
0.000923697
|
|
|
MNGIE
|
[NCBI]
|
0.000918946
|
|
|
CF
|
[NCBI]
|
0.000898605
|
|
|
MTND6
|
[NCBI]
|
0.000844575
|
|
|
MTTK
|
[NCBI]
|
0.000815387
|
|
|
POLG
|
[NCBI]
|
0.00080979
|
|
|
aging
|
[NCBI]
|
0.000792571
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
0.000792571
|
|
|
MTCO1
|
[NCBI]
|
0.000784987
|
|
|
MTND5
|
[NCBI]
|
0.000784019
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
0.000782769
|
|
|
MTND2
|
[NCBI]
|
0.000685658
|
|
|
MTRNR1
|
[NCBI]
|
0.000668634
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
0.000668461
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
0.000584166
|
|
|
MTND3
|
[NCBI]
|
0.000581737
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000567039
|
|
|
MTCYB
|
[NCBI]
|
0.000547033
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
0.000519435
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
0.000519435
|
|
|
MTCO3
|
[NCBI]
|
0.000491728
|
|
|
MTTS1
|
[NCBI]
|
0.000485062
|
|
|
SANDO
|
[NCBI]
|
0.00042104
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
0.000384086
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
0.000356706
|
|
|
MTND4L
|
[NCBI]
|
0.000340662
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
0.000324509
|
|
|
WFS1
|
[NCBI]
|
0.000307226
|
|
|
DGUOK
|
[NCBI]
|
0.000286341
|
|
|
MDM1
|
[NCBI]
|
0.000263577
|
|
|
C10ORF2
|
[NCBI]
|
0.000255383
|
|
|
SLC25A4
|
[NCBI]
|
0.00021979
|
|
|
endometrial cancer
|
[NCBI]
|
0.000216366
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
0.000216298
|
|
|
nephropathy, chronic tubulointerstitial
|
[NCBI]
|
0.000216298
|
|
|
NN
|
[NCBI]
|
0.000216298
|
|
|
striatonigral degeneration, infantile, mitochondrial
|
[NCBI]
|
0.000216298
|
|
|
COXPD1
|
[NCBI]
|
0.000216298
|
|
|
CVS
|
[NCBI]
|
0.000207861
|
|
|
MTTN
|
[NCBI]
|
0.000194245
|
|
|
PEOA4
|
[NCBI]
|
0.000172982
|
|
|
LIMM
|
[NCBI]
|
0.000172982
|
|
|
CRC
|
[NCBI]
|
0.000166142
|
|
|
TK2
|
[NCBI]
|
0.000163606
|
|
|
MG
|
[NCBI]
|
0.000159718
|
|
|
MTTI
|
[NCBI]
|
0.000158256
|
|
|
FSHMD1A
|
[NCBI]
|
0.000154608
|
|
|
MTTH
|
[NCBI]
|
0.000147386
|
|
|
PD
|
[NCBI]
|
0.000145197
|
|
|
LSFC
|
[NCBI]
|
0.00014021
|
|
|
MTTE
|
[NCBI]
|
0.000133547
|
|
|
MTTL2
|
[NCBI]
|
0.000129463
|
|
|
TFAM
|
[NCBI]
|
0.000128793
|
|
|
longevity
|
[NCBI]
|
0.000121856
|
|
|
mitochondrial myopathy
|
[NCBI]
|
0.000121856
|
|
|
FRDA
|
[NCBI]
|
0.000118911
|
|
|
MAFD6
|
[NCBI]
|
0.000118716
|
|
|
RPS12
|
[NCBI]
|
0.000118294
|
|
|
NIDDM
|
[NCBI]
|
0.000116182
|
|
|
MTTW
|
[NCBI]
|
0.000116078
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
0.000114973
|
|
|
deafness, aminoglycoside-induced
|
[NCBI]
|
0.000109048
|
|
|
PCH6
|
[NCBI]
|
0.000108129
|
|
|
renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial dna
|
[NCBI]
|
0.000108129
|
|
|
COXPD4
|
[NCBI]
|
0.000108129
|
|
|
COXPD2
|
[NCBI]
|
0.000108129
|
|
|
myoglobinuria, recurrent
|
[NCBI]
|
0.000108129
|
|
|
COXPD3
|
[NCBI]
|
0.000108129
|
|
|
proximal myopathy with focal depletion of mitochondria
|
[NCBI]
|
0.000108129
|
|
|
diarrhea, chronic, with villous atrophy
|
[NCBI]
|
0.000108129
|
|
|
TNF
|
[NCBI]
|
0.000105971
|
|
|
MTTS2
|
[NCBI]
|
9.70847e-05
|
|
|
MTTQ
|
[NCBI]
|
9.70847e-05
|
|
|
MTRNR2
|
[NCBI]
|
9.70847e-05
|
|
|
MTTV
|
[NCBI]
|
9.70847e-05
|
|
|
GLI3
|
[NCBI]
|
9.07662e-05
|
|
|
VEGF
|
[NCBI]
|
8.52124e-05
|
|
|
MTTG
|
[NCBI]
|
8.50523e-05
|
|
|
POLG2
|
[NCBI]
|
8.50523e-05
|
|
|
MPV17
|
[NCBI]
|
7.90904e-05
|
|
|
RPS14
|
[NCBI]
|
7.85827e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
7.67363e-05
|
|
|
POLRMT
|
[NCBI]
|
7.48522e-05
|
|
|
BJS
|
[NCBI]
|
6.50113e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
6.50113e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
6.50113e-05
|
|
|
oncocytoma
|
[NCBI]
|
6.50113e-05
|
|
|
MTATP8
|
[NCBI]
|
6.47148e-05
|
|
|
MTTR
|
[NCBI]
|
6.47148e-05
|
|
|
NRF1
|
[NCBI]
|
5.96058e-05
|
|
|
OPA1
|
[NCBI]
|
5.87953e-05
|
|
|
vater association
|
[NCBI]
|
5.74668e-05
|
|
|
HPA1
|
[NCBI]
|
5.74668e-05
|
|
|
DFNA1
|
[NCBI]
|
5.74668e-05
|
|
|
SUCLA2
|
[NCBI]
|
5.4502e-05
|
|
|
TUFM
|
[NCBI]
|
5.4502e-05
|
|
|
SURF1
|
[NCBI]
|
5.2911e-05
|
|
|
MLASA
|
[NCBI]
|
5.19078e-05
|
|
|
CYCS
|
[NCBI]
|
4.96482e-05
|
|
|
WFS1
|
[NCBI]
|
4.96482e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
4.75181e-05
|
|
|
DFNA4
|
[NCBI]
|
4.75181e-05
|
|
|
SOD2
|
[NCBI]
|
4.68266e-05
|
|
|
ENDOG
|
[NCBI]
|
4.67332e-05
|
|
|
GFM1
|
[NCBI]
|
4.67332e-05
|
|
|
CJD
|
[NCBI]
|
4.48865e-05
|
|
|
MODY
|
[NCBI]
|
4.42067e-05
|
|
|
CMT2A2
|
[NCBI]
|
4.39011e-05
|
|
|
humanin
|
[NCBI]
|
4.23525e-05
|
|
|
TRMU
|
[NCBI]
|
4.23525e-05
|
|
|
MTTF
|
[NCBI]
|
4.23525e-05
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
4.08334e-05
|
|
|
EGFR
|
[NCBI]
|
4.07031e-05
|
|
|
ACHE
|
[NCBI]
|
3.90794e-05
|
|
|
FXN
|
[NCBI]
|
3.59852e-05
|
|
|
RMRP
|
[NCBI]
|
3.58892e-05
|
|
|
SHEP1
|
[NCBI]
|
3.58379e-05
|
|
|
gracile syndrome
|
[NCBI]
|
3.58379e-05
|
|
|
TH
|
[NCBI]
|
3.43041e-05
|
|
|
ECGF1
|
[NCBI]
|
3.41213e-05
|
|
|
MTC
|
[NCBI]
|
3.37541e-05
|
|
|
COX7B
|
[NCBI]
|
3.23532e-05
|
|
|
AFG3L1
|
[NCBI]
|
3.23532e-05
|
|
|
TFB2M
|
[NCBI]
|
3.23532e-05
|
|
|
TOP1MT
|
[NCBI]
|
3.23532e-05
|
|
|
RPS3
|
[NCBI]
|
3.19321e-05
|
|
|
MTS
|
[NCBI]
|
3.18785e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
3.18785e-05
|
|
|
KTCN1
|
[NCBI]
|
3.18785e-05
|
|
|
PCNA
|
[NCBI]
|
3.10823e-05
|
|
|
NPHS1
|
[NCBI]
|
3.01762e-05
|
|
|
EPO
|
[NCBI]
|
2.86791e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
2.86204e-05
|
|
|
GFAP
|
[NCBI]
|
2.86107e-05
|
|
|
RP
|
[NCBI]
|
2.81386e-05
|
|
|
ACH
|
[NCBI]
|
2.79934e-05
|
|
|
IDDM
|
[NCBI]
|
2.73234e-05
|
|
|
OPA1
|
[NCBI]
|
2.72627e-05
|
|
|
PPARGC1A
|
[NCBI]
|
2.64635e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
2.58687e-05
|
|
|
PHS
|
[NCBI]
|
2.58687e-05
|
|
|
MRPS12
|
[NCBI]
|
2.49424e-05
|
|
|
NDUFAF1
|
[NCBI]
|
2.49424e-05
|
|
|
RARS2
|
[NCBI]
|
2.49424e-05
|
|
|
SUCLG1
|
[NCBI]
|
2.49424e-05
|
|
|
sarcomeric muscle protein
|
[NCBI]
|
2.49424e-05
|
|
|
SSBP1
|
[NCBI]
|
2.49424e-05
|
|
|
MTTP
|
[NCBI]
|
2.49424e-05
|
|
|
FHM1
|
[NCBI]
|
2.35e-05
|
|
|
MPO
|
[NCBI]
|
2.26351e-05
|
|
|
CDLS1
|
[NCBI]
|
2.24323e-05
|
|
|
ATP5J
|
[NCBI]
|
2.21532e-05
|
|
|
RRM2B
|
[NCBI]
|
2.21532e-05
|
|
|
mitochondrial ribosomal protein s16: mrps16
|
[NCBI]
|
2.21532e-05
|
|
|
MTTY
|
[NCBI]
|
2.21532e-05
|
|
|
ZNF365
|
[NCBI]
|
2.21532e-05
|
|
|
TSFM
|
[NCBI]
|
2.21532e-05
|
|
|
MTTA
|
[NCBI]
|
2.21532e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
2.14312e-05
|
|
|
DFNB1
|
[NCBI]
|
2.14312e-05
|
|
|
RNASEH1
|
[NCBI]
|
2.03463e-05
|
|
|
NDUFS6
|
[NCBI]
|
2.03463e-05
|
|
|
OXA1L
|
[NCBI]
|
2.03463e-05
|
|
|
FTMT
|
[NCBI]
|
2.03463e-05
|
|
|
NDUFS2
|
[NCBI]
|
2.03463e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.96036e-05
|
|
|
SLC25A19
|
[NCBI]
|
1.9006e-05
|
|
|
HSPE1
|
[NCBI]
|
1.9006e-05
|
|
|
RPS2
|
[NCBI]
|
1.9006e-05
|
|
|
NDUFV2
|
[NCBI]
|
1.9006e-05
|
|
|
PUS1
|
[NCBI]
|
1.9006e-05
|
|
|
RPS11
|
[NCBI]
|
1.9006e-05
|
|
|
ATP5A1
|
[NCBI]
|
1.9006e-05
|
|
|
RPL11
|
[NCBI]
|
1.9006e-05
|
|
|
membrane-associated protein 17
|
[NCBI]
|
1.9006e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.83444e-05
|
|
|
SLC25A12
|
[NCBI]
|
1.79405e-05
|
|
|
NDUFS1
|
[NCBI]
|
1.79405e-05
|
|
|
COX4I1
|
[NCBI]
|
1.79405e-05
|
|
|
NEIL1
|
[NCBI]
|
1.79405e-05
|
|
|
APOE
|
[NCBI]
|
1.75825e-05
|
|
|
NOS3
|
[NCBI]
|
1.75356e-05
|
|
|
CAMK4
|
[NCBI]
|
1.70566e-05
|
|
|
PCK2
|
[NCBI]
|
1.70566e-05
|
|
|
NDUFS8
|
[NCBI]
|
1.70566e-05
|
|
|
GJB2
|
[NCBI]
|
1.66634e-05
|
|
|
FTD
|
[NCBI]
|
1.64973e-05
|
|
|
ACTN3
|
[NCBI]
|
1.63017e-05
|
|
|
RPS13
|
[NCBI]
|
1.63017e-05
|
|
|
SDHA
|
[NCBI]
|
1.63017e-05
|
|
|
DNAJA3
|
[NCBI]
|
1.63017e-05
|
|
|
BCS1L
|
[NCBI]
|
1.63017e-05
|
|
|
CCKBR
|
[NCBI]
|
1.56433e-05
|
|
|
LPL
|
[NCBI]
|
1.5281e-05
|
|
|
SCO2
|
[NCBI]
|
1.50598e-05
|
|
|
TST
|
[NCBI]
|
1.50598e-05
|
|
|
ACO2
|
[NCBI]
|
1.45362e-05
|
|
|
DCK
|
[NCBI]
|
1.44698e-05
|
|
|
CAT
|
[NCBI]
|
1.43463e-05
|
|
|
HSPD1
|
[NCBI]
|
1.32278e-05
|
|
|
ALD
|
[NCBI]
|
1.29305e-05
|
|
|
TD1
|
[NCBI]
|
1.28882e-05
|
|
|
SLC25A1
|
[NCBI]
|
1.28577e-05
|
|
|
YY1
|
[NCBI]
|
1.28577e-05
|
|
|
MCOLN1
|
[NCBI]
|
1.28577e-05
|
|
|
ACO1
|
[NCBI]
|
1.28577e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.25132e-05
|
|
|
DSCR1
|
[NCBI]
|
1.25132e-05
|
|
|
AGXT
|
[NCBI]
|
1.21911e-05
|
|
|
POLD1
|
[NCBI]
|
1.18886e-05
|
|
|
USH1C
|
[NCBI]
|
1.16037e-05
|
|
|
DNM1L
|
[NCBI]
|
1.10793e-05
|
|
|
PPARD
|
[NCBI]
|
1.10793e-05
|
|
|
RPS19
|
[NCBI]
|
1.03861e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
9.82804e-06
|
|
|
DLD
|
[NCBI]
|
9.41665e-06
|
|
|
CAPN3
|
[NCBI]
|
8.91887e-06
|
|
|
CYBB
|
[NCBI]
|
8.61468e-06
|
|
|
NPS
|
[NCBI]
|
8.59447e-06
|
|
|
FOXO1A
|
[NCBI]
|
8.06158e-06
|
|
|
BAX
|
[NCBI]
|
7.93338e-06
|
|
|
OPTN
|
[NCBI]
|
7.93338e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
7.68765e-06
|
|
|
ACADS
|
[NCBI]
|
7.12794e-06
|
|
|
AD
|
[NCBI]
|
6.73641e-06
|
|
|
CHH
|
[NCBI]
|
5.9123e-06
|
|
|
OTC
|
[NCBI]
|
5.8697e-06
|
|
|
BCL2
|
[NCBI]
|
5.79318e-06
|
|
|
DHFR
|
[NCBI]
|
4.22212e-06
|
|
|
ALS1
|
[NCBI]
|
3.96599e-06
|
|
|
MYOC
|
[NCBI]
|
3.38873e-06
|
|
|
CMH
|
[NCBI]
|
3.27942e-06
|
|
|
MC1R
|
[NCBI]
|
3.24041e-06
|
|
|
BL
|
[NCBI]
|
3.15643e-06
|
|
|
MEN2A
|
[NCBI]
|
3.12238e-06
|
|
|
HBB
|
[NCBI]
|
2.9597e-06
|
|
|
APOB
|
[NCBI]
|
2.92947e-06
|
|
|
HPRT1
|
[NCBI]
|
2.6842e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.60409e-06
|
|
|
PPARA
|
[NCBI]
|
2.20612e-06
|
|
|
UCP1
|
[NCBI]
|
2.15303e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.9219e-06
|
|
|
TERT
|
[NCBI]
|
1.70331e-06
|
|
|
AGER
|
[NCBI]
|
1.55542e-06
|
|
|
TTR
|
[NCBI]
|
1.54533e-06
|
|
|
HD
|
[NCBI]
|
1.52268e-06
|
|
|
HFE
|
[NCBI]
|
1.32285e-06
|
|
|
G6PD
|
[NCBI]
|
1.3204e-06
|
|
|
XDH
|
[NCBI]
|
1.02828e-06
|
|
|
PCD
|
[NCBI]
|
9.49018e-07
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
5.80469e-07
|
|
|
GHR
|
[NCBI]
|
3.51842e-07
|
|
|
TNFSF10
|
[NCBI]
|
2.30193e-07
|
|
|
HP
|
[NCBI]
|
2.04151e-07
|
|
|
MB
|
[NCBI]
|
1.83852e-07
|
|
|
IAPP
|
[NCBI]
|
1.31709e-07
|
|
|
ACE
|
[NCBI]
|
9.00683e-08
|
|
|
FRAP1
|
[NCBI]
|
6.28838e-08
|
|
|
GAPDH
|
[NCBI]
|
3.00749e-08
|
|
|
COMT
|
[NCBI]
|
1.23413e-08
|
|